
Wayne T. Hockmeyer, Ph.D. has served as a
director since February 2002. Dr. Hockmeyer founded MedImmune, Inc., a
biotechnology company, in April 1988 and served until October 2000 as the chief
executive officer of MedImmune. In October 2000, Dr. Hockmeyer relinquished his
position as chief executive officer and now serves as chairman of the board of
directors, MedImmune, Inc. and president of MedImmune Ventures, Inc., a
wholly-owned subsidiary of MedImmune, Inc. Dr. Hockmeyer also serves as a
director of Advancis Pharmaceutical Corporation, GenVec, Inc., Tercica, Inc.
and TolerRx, Inc. Dr. Hockmeyer was recognized, in 1998, by the University of
Florida as a Distinguished Alumnus and in 2002 was awarded a Doctor of Science
honoris causa from Purdue University. Dr. Hockmeyer holds a B.S. from Purdue
University and a Ph.D. from the University of Florida.